Last reviewed · How we verify
NCT01564472
Validation of Sleepware G3 Autoscoring Algorithm
trial testing PSG Scoring in Polysomnography Scoring. Withdrawn.
Quick facts
| Lead sponsor | Philips Respironics |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
Drugs / interventions tested
- PSG Scoring
Conditions studied
- Polysomnography Scoring — all drugs for Polysomnography Scoring →
Sponsor
Philips Respironics
Who can join
21 and older, any sex, with Polysomnography Scoring. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to validate the ability of the Sleepware G3 polysomnography software platform to correctly identify and score sleep related events.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01564472
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Philips Respironics trials
Trials by the same sponsor.
- NCT03933462 — A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD · NA · completed
- NCT03948152 — A Study to Determine Preferences Towards Interface Products · NA · completed
- NCT03851510 — Determination of the Prevalence and Severity of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease Pati · terminated
- NCT03665844 — Smart Sleep In-home Validation Extension Study · NA · completed
- NCT03590795 — VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01564472 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philips Respironics
- Last refreshed: 8 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01564472.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing